MA

Showing 10 posts of 70 posts found.

India’s Piramal at centre of buy-out speculation

February 9, 2009
Sales and Marketing MA, Piramal

Indian pharmaceutical company Piramal has denied that it ready to sell up to one of the global giants of the …

Crucell linked with new takeover suitors

January 29, 2009
Sales and Marketing Crucell, MA

Dutch vaccines firm Crucell could be snapped up by other pharmaceutical companies after Wyeth pulled out of negotiations to buy …

Pfizer unveils $68 billion takeover of Wyeth

January 26, 2009
Sales and Marketing MA, Pfizer

Pfizer has unveiled a deal to acquire Wyeth for $68 billion, creating a new giant in pharmaceuticals, biotech, vaccines, consumer …

Pfizer to make merger bid for Wyeth

January 26, 2009
Sales and Marketing MA, Pfizer

Pfizer looks set to make a multi-billion dollar takeover of fellow US pharma company Wyeth.The world's largest pharma company, Pfizer …

Amgen could be Pfizer takeover target

December 18, 2008
Sales and Marketing Amgen, MA, Pfizer

Pfizer could be preparing itself to buy Amgen to maintain its lead in the sector, according to a leading analyst. …

GSK to acquire Hepatitis C specialists Genelabs

October 30, 2008
Sales and Marketing GSK, Genelabs, MA

GlaxoSmithKline is to pay $57 million (£35 million) for Genelabs, California-based specialists in infectious diseases, including hepatitis C. The companies …

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008
Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

Sanofi seals Zentiva deal with improved offer

September 23, 2008
Sales and Marketing MA, Sanofi, generics

Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …

Shire to buy up German biotech

July 3, 2008
Sales and Marketing MA, biotech

Shire is set to acquire German biotech firm Jerini, in a bid to expand its portfolio of treatments for rare …

Roche to buy Piramed

April 15, 2008
Sales and Marketing MA, Piramed

 Roche is set to pay $160 million (£315 million) to buy UK biotech company Piramed, a move which will further …

The Gateway to Local Adoption Series

Latest content